LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Vaxart Inc

Uždarymo kaina

0.4 2.56

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.39

Max

0.4

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-3.6M

-16M

Pardavimai

5.7M

21M

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-74.684

Darbuotojai

105

EBITDA

3.7M

-8.6M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+400% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

10M

103M

Ankstesnė atidarymo kaina

-2.16

Ankstesnė uždarymo kaina

0.4

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

Vaxart Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-05 20:45; UTC

Uždarbis

Broadcom 2Q Sales Climb on Booming AI Demand

2025-06-05 23:45; UTC

Rinkos pokalbiai

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

2025-06-05 23:44; UTC

Rinkos pokalbiai

Gold Edges Higher on Weak U.S. Data -- Market Talk

2025-06-05 23:30; UTC

Rinkos pokalbiai

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

2025-06-05 21:32; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-05 20:45; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:24; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Rev $15B >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Net $4.97B >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Adj EPS $1.58 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q EPS $1.03 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom Sees 3Q Rev $15.8B >AVGO

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

2025-06-05 19:22; UTC

Rinkos pokalbiai

Oil Futures Resume Upward Moves -- Market Talk

2025-06-05 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025-06-05 18:32; UTC

Rinkos pokalbiai

Gold Slips After Trump-Xi Call -- Market Talk

2025-06-05 18:26; UTC

Uždarbis

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

2025-06-05 18:06; UTC

Rinkos pokalbiai

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

2025-06-05 16:30; UTC

Įsigijimai, susijungimai, perėmimai

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

2025-06-05 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-05 16:18; UTC

Rinkos pokalbiai

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

2025-06-05 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-06-05 16:12; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-06-05 16:12; UTC

Rinkos pokalbiai

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

2025-06-05 16:03; UTC

Rinkos pokalbiai

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

2025-06-05 15:49; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Vaxart Inc Prognozė

Kainos tikslas

By TipRanks

400% į viršų

12 mėnesių prognozė

Vidutinis 2 USD  400%

Aukščiausias 2 USD

Žemiausias 2 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Vaxart Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

0.4007 / 0.4252Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.